Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome
- PMID: 20963561
- DOI: 10.1007/s12020-009-9277-9
Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome
Abstract
Glucocorticoid receptor (GR) transduces the glucocorticoid (GC) signal that could lead to metabolic derangements depending on the tissue responsiveness to GC. We aimed to investigate possible causative relation of the GR functional properties in peripheral blood mononuclear cells of women with polycystic ovary syndrome (PCOS), with their clinical and biochemical characteristics. Thirty women with PCOS [mean age: 26.5 ± 5.1 years, mean body mass index (BMI) 24.5 ± 5 kg/m(2)], and thirty respective controls were analyzed for the number of GR sites per cell (B (max)), apparent equilibrium dissociation constant (K (d)), and binding potency (GR potency). A strong association between B (max) and K (d) (r = 0.70, P < 0.0001), and GR potency with age (r = 0.49, P = 0.009) was observed in PCOS women. The multiple regression analyses within the PCOS group revealed that independent predictors for K (d) were BMI, total cholesterol, and dehydroepiandrosterone-sulfate (DHEA-S) (r = 0.58, P = 0.038), while for GR potency (r = 0.687, P = 0.013) were age, BMI, DHEA-S, and basal cortisol concentration. The results suggest that PCOS pathophysiology may be related to alterations of a cross stalk between glucocorticoid signaling, age, and metabolic parameters. These findings should be further explored in studies on the role of GR in PCOS-related metabolic derangements.
Similar articles
-
The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.Hormones (Athens). 2015 Jan-Mar;14(1):109-17. doi: 10.14310/horm.2002.1526. Hormones (Athens). 2015. PMID: 25402380
-
Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.Exp Clin Endocrinol Diabetes. 2011 Nov;119(10):636-43. doi: 10.1055/s-0031-1283122. Epub 2011 Nov 8. Exp Clin Endocrinol Diabetes. 2011. PMID: 22068557
-
Glucocorticoid receptors on mononuclear leukocytes in polycystic ovary syndrome.Int J Gynaecol Obstet. 1998 Oct;63(1):33-7. doi: 10.1016/s0020-7292(98)00126-x. Int J Gynaecol Obstet. 1998. PMID: 9849709 Clinical Trial.
-
DHEA, DHEAS and PCOS.J Steroid Biochem Mol Biol. 2015 Jan;145:213-25. doi: 10.1016/j.jsbmb.2014.06.003. Epub 2014 Jul 5. J Steroid Biochem Mol Biol. 2015. PMID: 25008465 Review.
-
Polycystic Ovary Syndrome Pathophysiology: Integrating Systemic, CNS and Circadian Processes.Front Biosci (Landmark Ed). 2024 Jan 18;29(1):24. doi: 10.31083/j.fbl2901024. Front Biosci (Landmark Ed). 2024. PMID: 38287831 Review.
Cited by
-
Identification of new biomarker candidates for glucocorticoid induced insulin resistance using literature mining.BioData Min. 2013 Feb 4;6(1):2. doi: 10.1186/1756-0381-6-2. BioData Min. 2013. PMID: 23379763 Free PMC article.
-
Insulin resistance and acne: a new risk factor for men?Endocrine. 2012 Dec;42(3):555-60. doi: 10.1007/s12020-012-9647-6. Epub 2012 Mar 25. Endocrine. 2012. PMID: 22447309
-
Endometrial Heparin-Binding Epidermal Growth Factor Gene Expression and Hormone Level Changes in Implantation Window of Obese Women with Polycystic Ovarian Syndrome.Biomedicines. 2023 Jan 19;11(2):276. doi: 10.3390/biomedicines11020276. Biomedicines. 2023. PMID: 36830813 Free PMC article.
-
Overview of the detection methods for equilibrium dissociation constant KD of drug-receptor interaction.J Pharm Anal. 2018 Jun;8(3):147-152. doi: 10.1016/j.jpha.2018.05.001. Epub 2018 May 5. J Pharm Anal. 2018. PMID: 29922482 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous